Skip to content

拜恩泰科

US · BNTX #801 按市值排名 上市于 2019
87.71 -2.49 -2.76%
实时 - 追踪5344个代码 - 心跳于487秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了3家。
  • 机构持股总比例基本持平。

机构持股

机构持股比例
60.59% -0.02pp
机构数量
401 -3
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

VC/PE Fund41.77%
Individual/Insider16.05%
Mutual Fund13.85%
Hedge Fund2.56%
Private Company0.99%
Public Company0.93%
Sovereign Wealth Fund0.29%
Government Pension Fund0.17%
Other23.37%

主要股东 截至 2026-03-31

AT Impf GmbH 40.49% · 101.70M 股
Ugur Sahin 15.65% · 39.31M 股
FMR 3.01% · 7.56M 股
PRIMECAP Management Company 1.50% · 3.77M 股
Dodge & Cox 1.46% · 3.68M 股
T. Rowe Price Group, Inc. 0.89% · 2.23M 股
Flossbach von Storch SE 0.89% · 2.23M 股
BlackRock 0.74% · 1.85M 股
Temasek Holdings 0.60% · 1.51M 股
BNP Paribas Financial Markets SNC 0.53% · 1.32M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 10次买入 · 19次卖出

姓名职务持股比例
AT Impf GmbH -- 40.49%
Ugur Sahin Co-Founder, CEO & Chair of the Management Board 15.65%
Sierk Pötting MD, COO & Member of Management Board 0.22%
Helmut Jeggle Independent Supervisory Board Chairman 0.13%
Ozlem Tureci Co-Founder, Chief Medical Officer & Member of Management Board 0.05%
James Timothy Ryan Chief Legal Officer & Member of the Management Board 0.00%
Rudolf Staudigl Supervisory Board Member 0.00%
Anja Morawietz Supervisory Board Member 0.00%
Ryan Richardson Chief Strategy Officer, MD & Member of Management Board --
Salvia GmbH -- --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-10-01 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -34,000 $96.72–97.46
2026-09-29 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -66,000 $98.12–98.26
2026-09-27 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -61,000 $98.47–98.69
2026-09-23 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -69,000 $98.99–99.40
2026-09-21 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -79,000 $97.81–100.72
2026-09-17 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -64,000 $96.22–98.60
2026-09-15 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -49,000 $96.09–96.49
2026-09-13 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Private Disposition -86,000 $96.93–99.45
2026-09-09 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -20,500 $96.31
2026-09-08 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -73,000 $97.78–99.20
2026-09-03 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Automatic Disposition -76,500 $102.85–103.52
2026-09-02 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Intent to Sell (Form 144) -858,209 $103.81
2026-05-12 Ugur Sahin Co-Founder, CEO & Chair of the Management Board Intent to Sell (Form 144) -858,209 $93.66
2026-05-11 Sierk Pötting MD, COO & Member of Management Board Other Derivative Acquisition +10,069 --
2026-05-11 Sierk Pötting MD, COO & Member of Management Board Other Derivative Acquisition +12,586 --
2026-05-11 James Timothy Ryan Chief Legal Officer & Member of the Management Board Other Derivative Acquisition +10,069 --
2026-05-11 James Timothy Ryan Chief Legal Officer & Member of the Management Board Other Derivative Acquisition +12,586 --
2026-05-11 Annemarie Hanekamp Chief Commercial Officer Other Derivative Acquisition +10,069 --
2026-05-11 Annemarie Hanekamp Chief Commercial Officer Other Derivative Acquisition +12,586 --
2026-05-11 Ramon Zapata-Gomez CFO & Member of Management Board Other Derivative Acquisition +15,103 --

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:30 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

拜恩泰科 讨论区 0 条评论

发表评论